$0.3101
0.047117.91%
Last update: Oct 2, 2:58 PM
ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc.
ARDSOTCEM
ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $0.00 | $0.33 | $-0.22 | $-0.27 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $417000 | $19.6M | $1.1M | $1.2M |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 21, 2022 | $-0.47 | $-0.17 | -176.5 % |
| Q2 | Aug 16, 2022 | $-0.45 | $-0.06 | -650.0 % |
| Q1 | May 16, 2022 | $-0.44 | $-0.51 | 13.7 % |
| Q4 | Mar 31, 2022 | $-0.92 | $-0.41 | -124.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 21, 2022 | $399.00K | $7.47M | -94.7 % |
| Q2 | Aug 16, 2022 | $292.00K | $10.46M | -97.2 % |
| Q1 | May 16, 2022 | $1.19M | $2.00M | -40.6 % |
| Q4 | Mar 31, 2022 | $570.00K | $1.90M | -70.0 % |
